Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Orphan Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oncology Drugs
1.2.3 Gastrointestinal Drugs
1.2.4 Neurology Drugs
1.2.5 Cardio-vascular Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Pediatric Orphan Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Orphan Drugs Market Perspective (2018-2029)
2.2 Pediatric Orphan Drugs Growth Trends by Region
2.2.1 Global Pediatric Orphan Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pediatric Orphan Drugs Historic Market Size by Region (2018-2023)
2.2.3 Pediatric Orphan Drugs Forecasted Market Size by Region (2024-2029)
2.3 Pediatric Orphan Drugs Market Dynamics
2.3.1 Pediatric Orphan Drugs Industry Trends
2.3.2 Pediatric Orphan Drugs Market Drivers
2.3.3 Pediatric Orphan Drugs Market Challenges
2.3.4 Pediatric Orphan Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Orphan Drugs Players by Revenue
3.1.1 Global Top Pediatric Orphan Drugs Players by Revenue (2018-2023)
3.1.2 Global Pediatric Orphan Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Pediatric Orphan Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatric Orphan Drugs Revenue
3.4 Global Pediatric Orphan Drugs Market Concentration Ratio
3.4.1 Global Pediatric Orphan Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Orphan Drugs Revenue in 2022
3.5 Pediatric Orphan Drugs Key Players Head office and Area Served
3.6 Key Players Pediatric Orphan Drugs Product Solution and Service
3.7 Date of Enter into Pediatric Orphan Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Orphan Drugs Breakdown Data by Type
4.1 Global Pediatric Orphan Drugs Historic Market Size by Type (2018-2023)
4.2 Global Pediatric Orphan Drugs Forecasted Market Size by Type (2024-2029)
5 Pediatric Orphan Drugs Breakdown Data by Application
5.1 Global Pediatric Orphan Drugs Historic Market Size by Application (2018-2023)
5.2 Global Pediatric Orphan Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pediatric Orphan Drugs Market Size (2018-2029)
6.2 North America Pediatric Orphan Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pediatric Orphan Drugs Market Size by Country (2018-2023)
6.4 North America Pediatric Orphan Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Orphan Drugs Market Size (2018-2029)
7.2 Europe Pediatric Orphan Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pediatric Orphan Drugs Market Size by Country (2018-2023)
7.4 Europe Pediatric Orphan Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Orphan Drugs Market Size (2018-2029)
8.2 Asia-Pacific Pediatric Orphan Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Pediatric Orphan Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Orphan Drugs Market Size (2018-2029)
9.2 Latin America Pediatric Orphan Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pediatric Orphan Drugs Market Size by Country (2018-2023)
9.4 Latin America Pediatric Orphan Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Orphan Drugs Market Size (2018-2029)
10.2 Middle East & Africa Pediatric Orphan Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Pediatric Orphan Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Recordati SpA
11.1.1 Recordati SpA Company Detail
11.1.2 Recordati SpA Business Overview
11.1.3 Recordati SpA Pediatric Orphan Drugs Introduction
11.1.4 Recordati SpA Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.1.5 Recordati SpA Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Pediatric Orphan Drugs Introduction
11.2.4 Novartis Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.2.5 Novartis Recent Development
11.3 Celgene
11.3.1 Celgene Company Detail
11.3.2 Celgene Business Overview
11.3.3 Celgene Pediatric Orphan Drugs Introduction
11.3.4 Celgene Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.3.5 Celgene Recent Development
11.4 Abbvie
11.4.1 Abbvie Company Detail
11.4.2 Abbvie Business Overview
11.4.3 Abbvie Pediatric Orphan Drugs Introduction
11.4.4 Abbvie Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.4.5 Abbvie Recent Development
11.5 Orpharma
11.5.1 Orpharma Company Detail
11.5.2 Orpharma Business Overview
11.5.3 Orpharma Pediatric Orphan Drugs Introduction
11.5.4 Orpharma Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.5.5 Orpharma Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Pediatric Orphan Drugs Introduction
11.6.4 Amgen Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.6.5 Amgen Recent Development
11.7 Amryt Pharma Plc.
11.7.1 Amryt Pharma Plc. Company Detail
11.7.2 Amryt Pharma Plc. Business Overview
11.7.3 Amryt Pharma Plc. Pediatric Orphan Drugs Introduction
11.7.4 Amryt Pharma Plc. Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.7.5 Amryt Pharma Plc. Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Pediatric Orphan Drugs Introduction
11.8.4 Johnson & Johnson Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.8.5 Johnson & Johnson Recent Development
11.9 GSK
11.9.1 GSK Company Detail
11.9.2 GSK Business Overview
11.9.3 GSK Pediatric Orphan Drugs Introduction
11.9.4 GSK Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.9.5 GSK Recent Development
11.10 Bristol-Myers Squibb Company
11.10.1 Bristol-Myers Squibb Company Company Detail
11.10.2 Bristol-Myers Squibb Company Business Overview
11.10.3 Bristol-Myers Squibb Company Pediatric Orphan Drugs Introduction
11.10.4 Bristol-Myers Squibb Company Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.10.5 Bristol-Myers Squibb Company Recent Development
11.11 Roche Holding
11.11.1 Roche Holding Company Detail
11.11.2 Roche Holding Business Overview
11.11.3 Roche Holding Pediatric Orphan Drugs Introduction
11.11.4 Roche Holding Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.11.5 Roche Holding Recent Development
11.12 Pfizer
11.12.1 Pfizer Company Detail
11.12.2 Pfizer Business Overview
11.12.3 Pfizer Pediatric Orphan Drugs Introduction
11.12.4 Pfizer Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.12.5 Pfizer Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Detail
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Pediatric Orphan Drugs Introduction
11.13.4 Sanofi Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.13.5 Sanofi Recent Development
11.14 Takeda
11.14.1 Takeda Company Detail
11.14.2 Takeda Business Overview
11.14.3 Takeda Pediatric Orphan Drugs Introduction
11.14.4 Takeda Revenue in Pediatric Orphan Drugs Business (2018-2023)
11.14.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details